Skip to Main Content
Qurgen Qurgen
Menu Button

May 21, 2026

Brand Icon
On May 21, 2026, Prof Jianjun Wang was invited to attend Tigermed’s ASCO Pre-Event Webinar as a Speaker to present Qurgen’s breakthrough cell converting cancer therapy and the recent progress of its Phase I clinical trial.

Recent news & press

Apr. 2026
No infusion related reactions (IRRs) were observed in patients enrolled in the ongoing Qurgen Clinical...
Learn More
Mar. 2026
Qurgen reported that numbers of patients with advanced solid tumors had received low-dose SON-DP treatment...
Learn More